Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L01 ANTINEOPLASTIC AGENTS
L01X OTHER ANTINEOPLASTIC AGENTS
L01XX Other antineoplastic agents
L01XX40 Omacetaxine mepesuccinate
D08956 Omacetaxine mepesuccinate (USAN) <US>
USP drug classification [BR:br08302]
Antineoplastics
Antineoplastics, Other
Omacetaxine Mepesuccinate
D08956 Omacetaxine mepesuccinate (USAN)
Target-based classification of drugs [BR:br08310]
Not elsewhere classified
Signaling molecules
Transcription factor
MYC
D08956 Omacetaxine mepesuccinate (USAN) <US>
Cellular process
Cell cycle
CCND1
D08956 Omacetaxine mepesuccinate (USAN) <US>
Apoptosis
MCL1
D08956 Omacetaxine mepesuccinate (USAN) <US>
New drug approvals in the USA [br08319.html]
New molecular entities and new therapeutic biological products
D08956
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D08956
Pharmacogenomic biomarkers [br08341.html]
Somatic variations in targeted cancer therapies
D08956